ArticleRSC advances2021
Application potential of biogenically synthesized silver nanoparticles using
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 34 citations in OpenAlex.
- Silver nanoparticles in biomedicine: green synthesis, precision theranostics, and future clinical translation.Folia microbiologica · 2026Review
- Green Synthesis of Silver Nanoparticles Using Cynoglossum creticum Leaf Extract: Eco-Friendly Approach for Antibacterial, Antioxidant, and Sensing Applications.Applied biochemistry and biotechnology · 2025Article
- Assessment of Purple Loosestrife (Pharmaceutics · 2025Article
- Antioxidants Acteoside and Orientin as Emerging Agents in Synergistic Cancer Therapy: A Focus on Innovative Applications.Antioxidants (Basel, Switzerland) · 2025Review
- Updated Review of Metal Nanoparticles Fabricated by Green Chemistry Using Natural Extracts: Biosynthesis, Mechanisms, and Applications.Bioengineering (Basel, Switzerland) · 2024Review
- Evaluation of Plant-Based Silver Nanoparticles for Antioxidant Activity and Promising Wound-Healing Applications.ACS omega · 2024Article
- Biosynthesis and characterization of silver nanoparticles synthesized using extracts ofRSC advances · 2024Article
- Phytofabrication of silver nanoparticles usingNanoscale advances · 2023Article
- Stable biogenic silver nanoparticles fromRSC advances · 2023Article
- Biosynthesis of Silver Nanoparticles UsingMolecules (Basel, Switzerland) · 2023Article
- Green Synthesis of Silver Nanoparticles UsingMolecules (Basel, Switzerland) · 2023Article
- Synthesis of a Ag/rGO nanocomposite usingRSC advances · 2022Article
- Green Synthesis and Characterization of Silver Nanoparticles Using aLife (Basel, Switzerland) · 2022Article
- Bell Shape Curves of Hemolysis Induced by Silver Nanoparticles: Review and Experimental Assay.Nanomaterials (Basel, Switzerland) · 2022Review
- Synergic effect of aqueous extracts ofRSC advances · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was designed to evaluate the optimal conditions for the eco-friendly synthesis of silver nanoparticles (AgNPs) using
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.